Literature DB >> 18685351

Neuroimaging of pain mechanisms.

Irene Tracey1.   

Abstract

PURPOSE OF REVIEW: Functional neuroimaging has made a huge impact scientifically, not least within the field of pain research. The noninvasive identification of pain mechanisms that underpin chronicity, such as central sensitization and other amplification processes related to the cognitive or emotional state of the patient, is of considerable interest to the clinical pain community and pharmaceutical industry. Relating data to a person's specific pain report or measure of pain relief provide a clearer understanding of the mechanisms driving and maintaining this complex experience. It is timely, therefore, to review the advances in neuroimaging applications to pain. RECENT
FINDINGS: New data have emerged to further support the descending modulatory system's critical role in chronic pain. The neural correlates that underpin tonic, ongoing and spontaneous pain in patients are being identified. Additionally, the prefrontal cortex is emerging as a critical brain region for pain processing, especially in patients. Finally, data from structural and molecular imaging studies are highlighting the extent of damage the brain sustains when patients live with their chronicity unrelieved.
SUMMARY: Neuroimaging tools have advanced our understanding of central pain mechanisms in normals and patients, forcing us to reconsider issues related to diagnosis and provision of treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18685351     DOI: 10.1097/SPC.0b013e3282efc58b

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  25 in total

Review 1.  Central pain mechanisms in chronic pain states--maybe it is all in their head.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-04       Impact factor: 4.098

Review 2.  Neuroimaging in chronic migraine.

Authors:  Luisa Chiapparini; Stefania Ferraro; Licia Grazzi; Gennaro Bussone
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

Review 3.  Pain and suicidality: insights from reward and addiction neuroscience.

Authors:  Igor Elman; David Borsook; Nora D Volkow
Journal:  Prog Neurobiol       Date:  2013-07-01       Impact factor: 11.685

Review 4.  Neuroimaging of neuropathic pain: review of current status and future directions.

Authors:  Soha Alomar; Mohamad Bakhaidar
Journal:  Neurosurg Rev       Date:  2016-12-14       Impact factor: 3.042

Review 5.  Targeted treatment of pruritus: a look into the future.

Authors:  H L Tey; G Yosipovitch
Journal:  Br J Dermatol       Date:  2011-05-30       Impact factor: 9.302

6.  Hippocampal correlates of pain in healthy elderly adults: a pilot study.

Authors:  M E Zimmerman; J W Pan; H P Hetherington; M L Lipton; K Baigi; R B Lipton
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

Review 7.  Mind-body interactions in pain: the neurophysiology of anxious and catastrophic pain-related thoughts.

Authors:  Claudia M Campbell; Robert R Edwards
Journal:  Transl Res       Date:  2009-01-01       Impact factor: 7.012

8.  individual variation in sleep quality and duration is related to cerebral mu opioid receptor binding potential during tonic laboratory pain in healthy subjects.

Authors:  Claudia M Campbell; Sara C Bounds; Hiroto Kuwabara; Robert R Edwards; James N Campbell; Jennifer A Haythornthwaite; Michael T Smith
Journal:  Pain Med       Date:  2013-09-18       Impact factor: 3.750

Review 9.  New insights into headache: an update on functional and structural imaging findings.

Authors:  Arne May
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

10.  Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.

Authors:  R A Moore; O A Moore; S Derry; P M Peloso; A R Gammaitoni; H Wang
Journal:  Ann Rheum Dis       Date:  2009-04-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.